Related references
Note: Only part of the references are listed.The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis
Zheng-sheng Yang et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)
Adriana H. Tremoulet et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Adjunctive therapies for Kawasaki disease
Anita J. Campbell et al.
JOURNAL OF INFECTION (2016)
Kawasaki Disease
Jane W. Newburger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN
Youngmin Youn et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
The epidemiology of Kawasaki disease: a global update
Surjit Singh et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease
Xi Yang et al.
CARDIOLOGY IN THE YOUNG (2015)
Effect of Tumor Necrosis Factor Inhibitor Treatment on Proximal Right Coronary Chronic Total Occlusion in a Patient With Rheumatoid Arthritis
Michael Behnes et al.
CIRCULATION (2015)
Kawasaki disease: a comprehensive review of treatment options
Rupal M. Patel et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Kawasaki disease: insights into pathogenesis and approaches to treatment
Stanford T. Shulman et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease
Meng Wei et al.
PEDIATRIC CARDIOLOGY (2015)
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
Adriana H. Tremoulet et al.
LANCET (2014)
Atorvastatin Safety in Kawasaki Disease Patients With Coronary Artery Aneurysms
Elizabeth Niedra et al.
PEDIATRIC CARDIOLOGY (2014)
High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report
Ashley Shafferman et al.
PEDIATRIC RHEUMATOLOGY (2014)
Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin
J. C. Burns et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
Shaojie Chen et al.
HEART (2013)
A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease
Bo-hui Zhu et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
Adriana H. Tremoulet et al.
JOURNAL OF PEDIATRICS (2012)
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
Tohru Kobayashi et al.
LANCET (2012)
Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
Shohei Ogata et al.
PEDIATRICS (2012)
Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease
Tatsunori Hokosaki et al.
PEDIATRICS INTERNATIONAL (2012)
Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study
Mary Beth Son et al.
JOURNAL OF PEDIATRICS (2011)
Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance
Lynn A. Sleeper et al.
JOURNAL OF PEDIATRICS (2011)
Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease
Nadine F. Choueiter et al.
JOURNAL OF PEDIATRICS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Role for TNF in atherosclerosis? Lessons from autoimmune disease
Gayle E. McKellar et al.
NATURE REVIEWS CARDIOLOGY (2009)
Infliximab Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
Jane C. Burns et al.
JOURNAL OF PEDIATRICS (2008)
Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
Taek Jin Lee et al.
YONSEI MEDICAL JOURNAL (2008)
Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease
M Miura et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2005)
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association
JW Newburger et al.
PEDIATRICS (2004)
Re-treatment for immune globulin-resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy
M Ishii et al.
PEDIATRICS INTERNATIONAL (2001)
Share Paper
